GLP-1 / glucagon dual agonist · Altimmune
Track your Pemvidutide doses with Phaze
Pemvidutide is a GLP-1 / glucagon dual agonist from Altimmune. Phaze is a wellness and habit-tracking app, not a medical device, that gives Pemvidutide users dose tracking, Estimated Levels, side-effect intelligence, labs, and progress in one private place.
Pemvidutide, Investigational, not yet FDA approved.
Phaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Pemvidutide is investigational and not FDA-approved as of 2026; Phaze does not supply, prescribe, or recommend any medication. Estimated Levels is an illustration of the doses you log yourself, not a measurement, and is for information only. Always follow your healthcare provider's guidance.
GLP-1 / glucagon dual agonist, tracked in one calm app.
- Drug class
- GLP-1 / glucagon dual agonist
- Manufacturer
- Altimmune
- Status
- Investigational
- Route
- Injectable
Dose tracking, dialed in
Schedule, log, and visualize every Pemvidutide dose. Injection-site rotation, prep checklist, dose calendar, and reminders that fit your plan. Dose tracking is free.
Labs & Scans
Track lab work across 8 categories (GLP-1, metabolic, lipids, vitamins, kidney, liver, thyroid, inflammation). Manual entry is free; OCR lab-document import is part of Phaze Pro. For information only, not medical advice.
Body Composition (Beta)
See your weight trend with dose markers, BMI over time, and an AI photo estimate of body fat % and muscle (±3 to 5%, with a confidence level). Body Composition is in Beta and lives inside Labs & Scans.
Side effects & check-ins
Log nausea, fatigue, or any of 40 side effects with severity, then see trends like "Nausea is decreasing." Daily check-ins capture mood, energy, hunger, sleep, and bowel health.
Apple Watch & Estimated Levels
Estimated Levels draws the Pemvidutide doses you have logged as one curve across the dose cycle. It is free. Phaze also includes an Apple Watch app, widgets, and Live Activities.
Pemvidutide FAQ
Pemvidutide is a GLP-1 / glucagon dual agonist from Altimmune. As of 2026 it is investigational and not FDA-approved. Phaze is a tracking tool, not a source or supplier. This is general information, not medical advice. Talk to your doctor.
Phaze supports Pemvidutide dose scheduling, injection-site rotation, a prep checklist, a dose calendar, and reminders. Estimated Levels shows where you are in your dose cycle. Dose tracking and Estimated Levels are free.
No. As of 2026, Pemvidutide is investigational and not FDA-approved. Phaze does not supply, prescribe, or recommend any medication, and never claims approval that does not exist. Always confirm regulatory status with your healthcare provider. This is general information, not medical advice.
It draws the doses you have logged as one curve across your dose cycle, each at the amount and time you entered. It is for information only, not medical advice. Always follow your healthcare provider's guidance.
Phaze is purpose-built for GLP-1 users: dose tracking, Estimated Levels, side-effect intelligence, Labs & Scans, protein-first nutrition, an Apple Watch app, and local-first privacy. Medical data is encrypted with AES-256-GCM in the Apple Keychain on iPhone and the Android Keystore on Android.
Track Pemvidutide the calm way.
Doses, labs, body, and meals, in one private app. Free to start.
Phaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Pemvidutide is investigational and not FDA-approved as of 2026; Phaze does not supply, prescribe, or recommend any medication. Estimated Levels is an illustration of the doses you log yourself, not a measurement, and is for information only. Always follow your healthcare provider's guidance.